CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors

NCT03511391 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Urothelial Carcinoma
Melanoma
Renal Cell Carcinoma
Non-small Cell Lung Cancer
Head and Neck Cancer

Interventions

DRUG: Nivolumab or Pembrolizumab or Atezolizumab
RADIATION: SBRT

Sponsor

University Hospital, Ghent

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]